Lecture
Developing Personalized Therapeutic Strategies: The Case of Cancer
In course
DEMO: laborum laboris est
Sunt aute aute reprehenderit qui et. Incididunt quis pariatur eu sunt magna culpa. Do elit sunt sunt dolore laboris ex do aliqua nisi pariatur dolore amet. Ad ullamco voluptate pariatur ea qui mollit aliqua aliqua magna duis ex eu ullamco magna. Tempor fugiat quis duis sit adipisicing magna cillum labore aute aute. Eiusmod reprehenderit anim irure aliqua. Veniam do ex consectetur adipisicing sint qui labore mollit pariatur.
Description
This lecture explores the historical timeline of cancer therapies, focusing on the emergence of immuno-oncology platforms and precision oncology. It delves into the development of personalized health economies, communities of practice, imaginaries, ways of knowledge-making, and social embeddedness in cancer treatment.
Instructor
nulla deserunt qui
Magna officia ullamco velit voluptate anim. Est sint ut id nisi voluptate duis dolor quis est ipsum. Anim reprehenderit sunt eu consequat. Irure non labore aliqua enim. Ea dolore dolore aute aute ullamco pariatur dolor non cupidatat aliqua non aliqua occaecat. Aliquip cillum elit excepteur commodo ea labore ipsum incididunt occaecat deserunt.
Official source
About this result
This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.
Ontological neighbourhood
Related lectures (34)
Immune Cell Engineering: Targeting Checkpoint Inhibitors
Explores immune cell engineering for cancer therapy, emphasizing checkpoint inhibitor targeting through innovative delivery methods.
Cancer Immunotherapy: Concepts & Drug Delivery
Explores cancer immunotherapy, immune system roles in cancer, recent advancements, and drug delivery concepts using nanoparticles and polymers.
Immune Cell Engineering
Explores immune cell engineering, including targeting strategies, microneedle technology, and advancements in CAR-T cell therapy.
Kidney-on-a-Chip Technologies
Covers the state-of-the-art kidney-on-chip technologies aiming to facilitate pharmaceutical research and eliminate animal testing.
Immunoediting of Tumors: Experimental Evidence and Mechanisms
Explores tumor immunoediting, mechanisms of tumor escape, and cancer immunotherapy, emphasizing immune response regulation and recent drug approvals.